Corneal Cross-Linking Window Absorption (CXL-WA) as an Adjuvant Therapy in the Management of Aspergillus niger Keratitis
المؤلفون المشاركون
Rosetta, Pietro
Legrottaglie, Emanuela F.
Pagano, Luca
Vinciguerra, Paolo
المصدر
Case Reports in Ophthalmological Medicine
العدد
المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-5، 5ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2018-12-10
دولة النشر
مصر
عدد الصفحات
5
التخصصات الرئيسية
الملخص EN
Purpose.
To evaluate the effectiveness of corneal cross-linking window absorption (CXL-WA) as an adjuvant therapy for Aspergillus keratitis.
Methods.
A 90-year-old male came to our clinic complaining of hyperemic conjunctivitis and progressive visual loss in the right eye.
Slit-lamp examination showed keratic precipitates, severe corneal opacity, and stromal edema.
Corneal scraping culture was positive for Aspergillus niger.
Because the clinical condition did not sufficiently improve with antifungal therapy, the patient underwent CXL-WA as an adjuvant therapy.
Results.
During the first week after treatment, the Tyndall effect, corneal edema, and signs of ocular inflammation progressively lessened.
At the third postoperative month, the cornea was stable without signs of fungal keratitis.
However, after this period, a descemetocele appeared in the cornea (2 × 2 mm in diameter), so the patient underwent a corneal penetrating keratoplasty.
Histological evaluation of the removed corneal tissue revealed the presence of hyphae and fungal infection.
Conclusions.
We reported a case of in vivo CXL-WA used as an adjuvant therapy for deep stromal Aspergillus keratitis.
CXL did not completely eradicate the fungal infection which caused perforation 4 months after treatment and it still cannot be considered a definitive solution to mycotic keratitis, which maintains a poor long-term prognosis.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Rosetta, Pietro& Legrottaglie, Emanuela F.& Pagano, Luca& Vinciguerra, Paolo. 2018. Corneal Cross-Linking Window Absorption (CXL-WA) as an Adjuvant Therapy in the Management of Aspergillus niger Keratitis. Case Reports in Ophthalmological Medicine،Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1146772
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Rosetta, Pietro…[et al.]. Corneal Cross-Linking Window Absorption (CXL-WA) as an Adjuvant Therapy in the Management of Aspergillus niger Keratitis. Case Reports in Ophthalmological Medicine No. 2018 (2018), pp.1-5.
https://search.emarefa.net/detail/BIM-1146772
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Rosetta, Pietro& Legrottaglie, Emanuela F.& Pagano, Luca& Vinciguerra, Paolo. Corneal Cross-Linking Window Absorption (CXL-WA) as an Adjuvant Therapy in the Management of Aspergillus niger Keratitis. Case Reports in Ophthalmological Medicine. 2018. Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1146772
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1146772
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر